Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience.
about
Pazopanib in the management of advanced soft tissue sarcomasUK guidelines for the management of soft tissue sarcomasThe Current Status of Solitary Fibrous Tumor: Diagnostic Features, Variants, and Genetics.Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis.Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline.Current and advancing systemic treatment options for soft tissue sarcomas.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Review of past and present clinical cases with a view to future treatment options.Phosphoproteomics in translational research: a sarcoma perspective.Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study().Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US.An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STManagement of the "Other" retroperitoneal sarcomas.2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma.
P2860
Q26746205-32A2BD19-1D45-4707-BC17-8B812A22B091Q28076730-E8B9EEBB-D205-4087-85DC-5A0D752773C7Q34045975-8B9BCE0C-FB8A-4260-9E41-32B4B087551AQ36097737-69C01C61-F075-434D-869D-6C784DCA0F06Q36530034-C28B341F-74D9-46F7-8E54-CBFB80F2D727Q38563242-C8FA4974-2D5B-4642-9001-ABD130259E1CQ38591828-58281BE2-E73A-4B4E-AC2A-F7F53AD385FAQ38688923-7C84FE04-5E08-46AF-82B6-F0975784A1BCQ38708614-C5192847-A836-402C-8639-D1B86E955445Q38936104-A1F45928-35F1-4FB1-B299-125AFE93A392Q39444949-D18C5E83-10A7-4190-990A-F561A6C25FB5Q39956277-DBEC45AF-A0E9-408D-9ABC-9A286474298BQ41105379-D0847704-4B35-4C1C-B70C-569873FD2ED1Q45983851-8C27110C-3E0B-46CF-AB11-25D5650E4BC9Q47666781-D39732FC-BF59-4D76-BB8B-6F2439A48E48Q48321145-FBCDC21E-E561-4F0F-A6B1-537B520A5D9DQ55715100-A8EA7AB3-8BBE-494A-8142-0C1E06D46E57
P2860
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pazopanib as first line treatm ...... l Marsden Hospital experience.
@ast
Pazopanib as first line treatm ...... l Marsden Hospital experience.
@en
type
label
Pazopanib as first line treatm ...... l Marsden Hospital experience.
@ast
Pazopanib as first line treatm ...... l Marsden Hospital experience.
@en
prefLabel
Pazopanib as first line treatm ...... l Marsden Hospital experience.
@ast
Pazopanib as first line treatm ...... l Marsden Hospital experience.
@en
P2093
P2860
P1476
Pazopanib as first line treatm ...... l Marsden Hospital experience.
@en
P2093
Aisha Miah
Charlotte Benson
Christina Messiou
Ian Judson
Juan Martin-Liberal
Khin Thway
Rolyn Alvarado
P2860
P2888
P356
10.1186/S13569-015-0022-2
P577
2015-02-02T00:00:00Z
P5875
P6179
1046212813